The European Union will seek to thrash out an agreement on sweeping rules to regulate artificial intelligence on Wednesday, following months of difficult negotiations in particular on how to monitor generative AI applications like ChatGPT.
ChatGPT wowed with its ability to produce poems and essays within seconds from simple user prompts.
AI proponents say the technology will benefit humanity, transforming everything from work to health care, but others worry about the risks it poses to society, fearing it could thrust the world into unprecedented chaos.
Brussels is bent on bringing big tech to heel with a powerful legal armory to protect EU citizens’ rights, especially those covering privacy and data protection.
The European Commission, the EU’s executive arm, first proposed an AI law in 2021 that would regulate systems based on the level of risk they posed. For example, the greater the risk to citizens’ rights or health, the greater the systems’ obligations.
Negotiations on the final legal text began in June, but a fierce debate in recent weeks over how to regulate general-purpose AI like ChatGPT and Google’s Bard chatbot threatened talks at the last minute.
Negotiators from the European Parliament and EU member states began discussions on Wednesday and the talks were expected to last into the evening.
Some member states worry that too much regulation will stifle innovation and hurt the chances of producing European AI giants to challenge those in the United States, including ChatGPT’s creator OpenAI as well as tech titans like Google and Meta.
Although there is no real deadline, senior EU figures have repeatedly said the bloc must finalize the law before the end of 2023.
Chasing local champions
EU diplomats, industry sources and other EU officials have warned the talks could end without an agreement as stumbling blocks remain over key issues.
Others have suggested that even if there is a political agreement, several meetings will still be needed to hammer out the law’s technical details.
And should EU negotiators reach agreement, the law would not come into force until 2026 at the earliest.
The main sticking point is over how to regulate so-called foundation models—designed to perform a variety of tasks—with France, Germany and Italy calling to exclude them from the tougher parts of the law.
“France, Italy and Germany don’t want a regulation for these models,” said German MEP Axel Voss, who is a member of the special parliamentary committee on AI.
The parliament, however, believes it is “necessary… for transparency” to regulate such models, Voss said.
Late last month, the three biggest EU economies published a paper calling for an “innovation-friendly” approach for the law known as the AI Act.
Berlin, Paris and Rome do not want the law to include restrictive rules for foundation models, but instead say they should adhere to codes of conduct.
Many believe this change in view is motivated by their wish to avoid hindering the development of European champions—and perhaps to help companies such as France’s Mistral AI and Germany’s Aleph Alpha.
Another sticking point is remote biometric surveillance—basically, facial identification through camera data in public places.
The EU parliament wants a full ban on “real time” remote biometric identification systems, which member states oppose. The commission had initially proposed that there could be exemptions to find potential victims of crime including missing children.
There have been suggestions MEPs could concede on this point in exchange for concessions in other areas.
Brando Benifei, one of the MEPs leading negotiations for the parliament, said he saw a “willingness” by everyone to conclude talks.
But, he added, “we are not scared of walking away from a bad deal”.
France’s digital minister Jean-Noel Barrot said it was important to “have a good agreement” and suggested there should be no rush for an agreement at any cost.
“Many important points still need to be covered in a single night,” he added.
Concerns over AI’s impact and the need to supervise the technology are shared worldwide.
US President Joe Biden issued an executive order in October to regulate AI in a bid to mitigate the technology’s risks.
News
Study Delivers Cancer Drugs Directly to the Tumor Nucleus
A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles. CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to [...]
Scientists Begin $14.2 Million Project To Decode the Body’s “Hidden Sixth Sense”
An NIH-supported initiative seeks to unravel how the nervous system tracks and regulates the body’s internal organs. How does your brain recognize when it’s time to take a breath, when your blood pressure has [...]
Scientists Discover a New Form of Ice That Shouldn’t Exist
Researchers at the European XFEL and DESY are investigating unusual forms of ice that can exist at room temperature when subjected to extreme pressure. Ice comes in many forms, even when made of nothing but water [...]
Nobel-winning, tiny ‘sponge crystals’ with an astonishing amount of inner space
The 2025 Nobel Prize in chemistry was awarded to Richard Robson, Susumu Kitagawa and Omar Yaghi on Oct. 8, 2025, for the development of metal-organic frameworks, or MOFs, which are tunable crystal structures with extremely [...]
Harnessing Green-Synthesized Nanoparticles for Water Purification
A new review reveals how plant- and microbe-derived nanoparticles can power next-gen water disinfection, delivering cleaner, safer water without the environmental cost of traditional treatments. A recent review published in Nanomaterials highlights the potential of green-synthesized nanomaterials (GSNMs) in [...]
Brainstem damage found to be behind long-lasting effects of severe Covid-19
Damage to the brainstem - the brain's 'control center' - is behind long-lasting physical and psychiatric effects of severe Covid-19 infection, a study suggests. Using ultra-high-resolution scanners that can see the living brain in [...]
CT scan changes over one year predict outcomes in fibrotic lung disease
Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in [...]
AI Spots Hidden Signs of Disease Before Symptoms Appear
Researchers suggest that examining the inner workings of cells more closely could help physicians detect diseases earlier and more accurately match patients with effective therapies. Researchers at McGill University have created an artificial intelligence tool capable of uncovering [...]
Breakthrough Blood Test Detects Head and Neck Cancer up to 10 Years Before Symptoms
Mass General Brigham’s HPV-DeepSeek test enables much earlier cancer detection through a blood sample, creating a new opportunity for screening HPV-related head and neck cancers. Human papillomavirus (HPV) is responsible for about 70% of [...]
Study of 86 chikungunya outbreaks reveals unpredictability in size and severity
The symptoms come on quickly—acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older [...]
Tiny Fat Messengers May Link Obesity to Alzheimer’s Plaque Buildup
Summary: A groundbreaking study reveals how obesity may drive Alzheimer’s disease through tiny messengers called extracellular vesicles released from fat tissue. These vesicles carry lipids that alter how quickly amyloid-β plaques form, a hallmark of [...]
Ozone exposure weakens lung function and reshapes the oral microbiome
Scientists reveal that short-term ozone inhalation doesn’t just harm the lungs; it reshapes the microbes in your mouth, with men facing the greatest risks. Ozone is a toxic environmental pollutant with wide-ranging effects on [...]
New study reveals molecular basis of Long COVID brain fog
Even though many years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are not completely understood. This is especially true for Long COVID, a chronic condition that [...]
Scientists make huge Parkinson’s breakthrough as they discover ‘protein trigger’
Scientists have, for the first time, directly visualised the protein clusters in the brain believed to trigger Parkinson's disease, bringing them one step closer to potential treatments. Parkinson's is a progressive incurable neurological disorder [...]
Alpha amino acids’ stability may explain their role as early life’s protein building blocks
A new study from the Hebrew University of Jerusalem published in the Proceedings of the National Academy of Sciences sheds light on one of life's greatest mysteries: why biology is based on a very specific set [...]
3D bioprinting advances enable creation of artificial blood vessels with layered structures
To explore possible treatments for various diseases, either animal models or human cell cultures are usually used first; however, animal models do not always mimic human diseases well, and cultures are far removed [...]
